Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
2 Risky Stocks That Could Continue Falling This Year
11:00am, Thursday, 30'th Jun 2022
Investors shouldn't assume that these struggling stocks will rebound anytime soon.
Novavax is part of the FDA's COVID-19 booster debate, but its vaccine still hasn't been authorized
02:45pm, Wednesday, 29'th Jun 2022
Novavax's NVAX, +0.85% COVID-19 vaccine candidate played a front-and-center role during this week's debate about how best to update the COVID-19 boosters to better protect against omicron.
Novavax Stock Is in Prime Position For Speculation
06:30am, Wednesday, 29'th Jun 2022
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on Novavax. The post Novavax Stock Is in Prime Position For Speculation appeared
3 Reasons to Buy Novavax and 1 to Sell
09:45am, Monday, 27'th Jun 2022
What does the future hold for this COVID-19 vaccination stock?
5 Unique Stocks That Can Generate Transformational Wealth
05:21am, Sunday, 26'th Jun 2022
These innovative businesses can put patient investors on a path to financial independence.
What Is Novavax?
05:45pm, Friday, 24'th Jun 2022
The FDA is expected to authorize a fourth COVID-19 vaccine. Here's how it might impact the pandemic.
Novavax (NVAX) Up as EMA Recommends COVID Jab for Adolescents
10:55am, Friday, 24'th Jun 2022
EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to Novavax's (NVAX) COVID-19 vaccine for use in adolescents. The stock rises 13.9%.
Why Novavax Stock Is Soaring This Week
04:29pm, Thursday, 23'rd Jun 2022
The company's COVID-19 vaccine could soon be available to adolescents in the European Union.
Why Novavax Stock Is Up 11% Today
03:47pm, Thursday, 23'rd Jun 2022
Novavax Inc (NASDAQ: NVAX) shares are trading higher Thursday after the company announced that its COVID-19 vaccine was recommended for an expanded conditional marketing authorization in the Europea
Novavax stock surges after COVID-19 vaccine recommended for expanded CMA in the EU for 12-17 year olds
03:04pm, Thursday, 23'rd Jun 2022
Shares of Novavax Inc. NVAX, +10.16% shot up 9.8% in afternoon trading Thursday, after the biotechnology company said its COVID-19 vaccine Nuvaxovid has been recommended by the Committee for Medicinal
Novavax (NVAX) Stock Gains 7% on EMA Recommendations
11:58am, Thursday, 23'rd Jun 2022
Novavax (NVAX) stock is gaining Thursday on news of a recommendation for the vaccine company's Covid-19 shot for teens in Europe. The post Novavax (NVAX) Stock Gains 7% on EMA Recommendations appeared
Why Novavax Stock Jumped Today
12:21pm, Wednesday, 22'nd Jun 2022
Novavax did a few encore presentations of its coronavirus vaccine efficacy and safety data at a conference.
This Warren Buffett Advice Could Save Your Portfolio in a Bear Market
11:45am, Wednesday, 22'nd Jun 2022
Buying more shares of a distressed stock could just end up putting more of your money at risk.
Why Novavax Stock Buckled Today
11:23am, Thursday, 16'th Jun 2022
Rising interest rates and successes by comeptitors make for a bad combination.
Novavax Stock Can Rally, But It's Still Facing Many Obstacles
07:34am, Thursday, 16'th Jun 2022
Novavax's vaccine will likely be approved by the FDA relatively soon, but NVAX stock is still facing many obstacles. The post Novavax Stock Can Rally, But It's Still Facing Many Obstacles appeared fir
